Compare American Airlines Group Inc (AAL) vs Aurora Cannabis Inc (ACB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Airlines Group Inc vs Aurora Cannabis Inc — how do they compare? American Airlines Group Inc trades at $15.34 (market cap $10.55B), while Aurora Cannabis Inc trades at $3.49 (market cap $178.92M). The key difference: American Airlines Group Inc is far larger — about 59× Aurora Cannabis Inc's market cap, and American Airlines Group Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| AAL | ACB | |
|---|---|---|
Market Cap | $10.55B | $178.92M |
Sector | Industrials | Health |
52-Week High | $18.15 | $6.23 |
52-Week Low | $10.18 | $2.58 |
Enterprise Value | $38.51B | $123.48M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AAL trades at $15.94, down 0.56% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, beating in Q1 and Q2 2026 but missing in Q4 2025. Revenue growth is steady, reaching $54.63 billion in 2025, though net income margins are thin at 0.2%. Debt-to-asset ratios have improved to 47.25% in 2025, but negative shareholder equity remains a concern. Recent news highlights advancements in sustainable aviation fuel and premium revenue growth.
The outlook is cautiously optimistic, supported by analyst consensus favoring buy ratings (44.74%) and a $19.63 price target, implying 23% upside. Key opportunities include robust premium demand and cost management, while risks involve fuel cost volatility, high debt, and competitive pressures. Earnings execution and fuel price trends will be critical for sustained stock performance.
Aurora Cannabis (ACB) trades at $2.99, up 0.34% with a bullish technical signal despite mixed earnings. The company achieved record annual medical cannabis revenue growth of 18% YoY to $288.6 million in FY2026, but faces margin pressure from Canadian reimbursement changes. Recent Q1 2027 earnings beat expectations with $0.04 EPS versus -$0.13 estimate, though revenue declined to $67.6 million. The stock shows strong institutional support with shareholder approval of board measures and EU-GMP certification for international expansion.
ACB presents a high-risk opportunity with significant volatility. While international medical cannabis growth and operational improvements provide upside potential, persistent net losses, negative ROE/ROA, and Canadian market challenges create substantial headwinds. Analyst consensus remains cautious with only 21% buy ratings, reflecting concerns about profitability timeline and competitive pressures in the evolving cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Airlines Group Inc
American Airlines is the world's largest airline by scheduled revenue passenger miles. The firm's major hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. After completing a major fleet renewal, the company has the youngest fleet of U.S. legacy carriers.
Read more on AAL →About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →
